Gilead Sciences Inc's Suppliers recorded an increase in sales by 9.19 % year on year in Q2 2026, sequentially sales grew by 9.21 %, Gilead Sciences Inc recorded an increase in cost of sales by 5.2 % year on year, sequentially cost of sales grew by 9.27 % in Q2.
Gilead Sciences Inc's Suppliers recorded an increase in sales by 9.19 % year on year in Q2 2026, sequentially sales grew by 9.21 %, Gilead Sciences Inc recorded increase in cost of sales by 5.2 % year on year, sequentially cost of sales grew by 9.27 % in Q2.
The company sources raw materials for clinical trials and product manufacturing from multiple suppliers and manages supply chain risks through inventory control, relationship management, and alternative sourcing. It owns or leases manufacturing facilities in the United States, Ireland, Canada, and the Netherlands, supporting activities such as manufacturing, quality control, packaging, labeling, and process development of APIs, drug products, biologics, and cell therapy products. Key locations include Foster City, La Verne, Oceanside, El Segundo, Santa Monica, Frederick, Cork, Dublin, Edmonton, and Hoofddorp. The company also utilizes contract manufacturing organizations (CMOs) and contract testing laboratories (CTLs) domestically and internationally, employing multiple CMOs per product to maintain primary and backup supply and manufacturing capacity. It is actively expanding its manufacturing capabilities and third-party supplier network for future products.
Gilead Sciences Inc's Comment on Supply Chain
The company sources raw materials for clinical trials and product manufacturing from multiple suppliers and manages supply chain risks through inventory control, relationship management, and alternative sourcing. It owns or leases manufacturing facilities in the United States, Ireland, Canada, and the Netherlands, supporting activities such as manufacturing, quality control, packaging, labeling, and process development of APIs, drug products, biologics, and cell therapy products. Key locations include Foster City, La Verne, Oceanside, El Segundo, Santa Monica, Frederick, Cork, Dublin, Edmonton, and Hoofddorp. The company also utilizes contract manufacturing organizations (CMOs) and contract testing laboratories (CTLs) domestically and internationally, employing multiple CMOs per product to maintain primary and backup supply and manufacturing capacity. It is actively expanding its manufacturing capabilities and third-party supplier network for future products.
GILD's Suppliers Net profit fell by
GILD's Suppliers Net margin fell in Q2 to
-1.63 %
8.56 %
GILD's Suppliers Net profit fell by -1.63 %
GILD's Suppliers Net margin fell in Q2 to 8.56 %
Gilead Sciences Inc's Suppliers Sales Growth
in Q2 2026 by Industry
Sources:
Gilead Sciences Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Gilead Sciences Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
4.31 % 